PKO Investment Management Joint Stock Co Makes New Investment in UnitedHealth Group Incorporated (NYSE:UNH)

PKO Investment Management Joint Stock Co acquired a new stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund acquired 12,089 shares of the healthcare conglomerate's stock, valued at approximately $6,115,000. UnitedHealth Group accounts for 0.8% of PKO Investment Management Joint Stock Co's investment portfolio, making the stock its 26th biggest holding.

A number of other hedge funds have also added to or reduced their stakes in the business. Norges Bank bought a new stake in UnitedHealth Group during the 4th quarter valued at $6,375,744,000. Raymond James Financial Inc. bought a new stake in UnitedHealth Group during the 4th quarter valued at $1,914,740,000. Amundi increased its stake in UnitedHealth Group by 97.2% during the 4th quarter. Amundi now owns 6,069,100 shares of the healthcare conglomerate's stock valued at $3,183,132,000 after purchasing an additional 2,991,470 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its stake in shares of UnitedHealth Group by 36.6% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 8,592,718 shares of the healthcare conglomerate's stock worth $4,346,712,000 after acquiring an additional 2,301,010 shares in the last quarter. Finally, Proficio Capital Partners LLC grew its stake in shares of UnitedHealth Group by 76,830.4% in the 4th quarter. Proficio Capital Partners LLC now owns 1,888,641 shares of the healthcare conglomerate's stock worth $955,388,000 after acquiring an additional 1,886,186 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In other news, Director Kristen Gil bought 3,700 shares of the firm's stock in a transaction dated Thursday, May 15th. The shares were acquired at an average price of $271.17 per share, for a total transaction of $1,003,329.00. Following the completion of the transaction, the director now directly owns 3,818 shares in the company, valued at $1,035,327.06. The trade was a 3,135.59% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CEO Stephen J. Hemsley bought 86,700 shares of the firm's stock in a transaction dated Friday, May 16th. The stock was purchased at an average price of $288.57 per share, for a total transaction of $25,019,019.00. Following the transaction, the chief executive officer now owns 679,493 shares of the company's stock, valued at approximately $196,081,295.01. This represents a 14.63% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have purchased a total of 109,408 shares of company stock valued at $31,607,768 over the last ninety days. Company insiders own 0.33% of the company's stock.

Wall Street Analyst Weigh In

Several analysts have recently issued reports on UNH shares. Argus lowered shares of UnitedHealth Group from a "buy" rating to a "hold" rating in a research note on Monday, April 21st. Wall Street Zen downgraded shares of UnitedHealth Group from a "buy" rating to a "hold" rating in a report on Saturday, May 24th. Robert W. Baird cut their price target on shares of UnitedHealth Group from $510.00 to $356.00 and set an "outperform" rating on the stock in a report on Wednesday, May 14th. JPMorgan Chase & Co. cut their price objective on shares of UnitedHealth Group from $525.00 to $405.00 and set an "overweight" rating for the company in a report on Thursday, May 15th. Finally, Morgan Stanley cut their price objective on shares of UnitedHealth Group from $563.00 to $374.00 and set an "overweight" rating for the company in a report on Wednesday, May 14th. One analyst has rated the stock with a sell rating, seven have given a hold rating, seventeen have given a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $441.87.

UnitedHealth Group Stock Down 0.0%

UnitedHealth Group stock traded down $0.01 during midday trading on Thursday, reaching $298.11. The company's stock had a trading volume of 16,213,440 shares, compared to its average volume of 6,743,288. The stock's 50-day simple moving average is $439.50 and its 200-day simple moving average is $498.65. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. UnitedHealth Group Incorporated has a 52-week low of $248.88 and a 52-week high of $630.73. The stock has a market capitalization of $270.42 billion, a P/E ratio of 19.23, a PEG ratio of 1.37 and a beta of 0.56.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. During the same quarter last year, the company posted $6.91 EPS. On average, sell-side analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.